WO2006018019A3 - SELEKTIVE INHIBITOREN DER 11ß-HYDROXYSTEROID-DEHYDROGENASE TYP 1 - Google Patents

SELEKTIVE INHIBITOREN DER 11ß-HYDROXYSTEROID-DEHYDROGENASE TYP 1 Download PDF

Info

Publication number
WO2006018019A3
WO2006018019A3 PCT/DE2005/001477 DE2005001477W WO2006018019A3 WO 2006018019 A3 WO2006018019 A3 WO 2006018019A3 DE 2005001477 W DE2005001477 W DE 2005001477W WO 2006018019 A3 WO2006018019 A3 WO 2006018019A3
Authority
WO
WIPO (PCT)
Prior art keywords
hydroxysteroid dehydrogenase
dehydrogenase type
selective inhibitors
type
hydroxysteroid
Prior art date
Application number
PCT/DE2005/001477
Other languages
English (en)
French (fr)
Other versions
WO2006018019A2 (de
Inventor
Edmund Maser
Andreas Blum
Original Assignee
Uksh Schleswig Holstein
Edmund Maser
Andreas Blum
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uksh Schleswig Holstein, Edmund Maser, Andreas Blum filed Critical Uksh Schleswig Holstein
Publication of WO2006018019A2 publication Critical patent/WO2006018019A2/de
Publication of WO2006018019A3 publication Critical patent/WO2006018019A3/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polymerisation Methods In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)

Abstract

Die Erfindung betrifft einen Inhibitor der 11ß-Hydroxysteroid-Dehydrogenase (11ß-HSD), der ausschließlich die 11ß-Hydroxysteroid-Dehydrogenase-Typ-1, nicht aber die 11ß­-Hydroxysteroid-Dehydrogenase-Typ-2 inhibiert.
PCT/DE2005/001477 2004-08-20 2005-08-22 SELEKTIVE INHIBITOREN DER 11ß-HYDROXYSTEROID-DEHYDROGENASE TYP 1 WO2006018019A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004040690A DE102004040690A1 (de) 2004-08-20 2004-08-20 Selektiver Inhibitor der 11beta-Hydroxysteroid Dehydrogenase
DE102004040690.1 2004-08-20

Publications (2)

Publication Number Publication Date
WO2006018019A2 WO2006018019A2 (de) 2006-02-23
WO2006018019A3 true WO2006018019A3 (de) 2006-05-11

Family

ID=35725750

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2005/001477 WO2006018019A2 (de) 2004-08-20 2005-08-22 SELEKTIVE INHIBITOREN DER 11ß-HYDROXYSTEROID-DEHYDROGENASE TYP 1

Country Status (2)

Country Link
DE (1) DE102004040690A1 (de)
WO (1) WO2006018019A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101496806B (zh) * 2008-01-31 2012-03-14 中国科学院上海药物研究所 苦瓜中提取的化合物在制备预防和治疗糖尿病和肥胖的药物中的用途

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4985248A (en) * 1987-06-18 1991-01-15 Yaguang Liu Pharmaceutical composition containing a safe extracts of fruits and vegetables for the treating and preventing of diabetes
WO2002072084A2 (en) * 2001-03-08 2002-09-19 Sterix Limited Glycyrrhetinic acid derivatives, progesterone and progesterone derivatives and their use for the manufacture of a medicament to inhibit 11beta-hydroxysteroid dehydrogenase activity
WO2002078617A2 (en) * 2001-03-28 2002-10-10 University Of South Florida Materials and methods for treatment of cancer and identification of anti-cancer compounds
JP2003104812A (ja) * 2001-07-26 2003-04-09 Nippon Fine Chem Co Ltd トリテルペン配糖体を含有する害虫防除剤

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003086410A1 (en) * 2002-04-05 2003-10-23 The University Of Edinburgh Pharmaceutical compositions comprising a 11-beta hydroxysteroid dehydrogenase inhibitor and a diuretic agent

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4985248A (en) * 1987-06-18 1991-01-15 Yaguang Liu Pharmaceutical composition containing a safe extracts of fruits and vegetables for the treating and preventing of diabetes
WO2002072084A2 (en) * 2001-03-08 2002-09-19 Sterix Limited Glycyrrhetinic acid derivatives, progesterone and progesterone derivatives and their use for the manufacture of a medicament to inhibit 11beta-hydroxysteroid dehydrogenase activity
WO2002078617A2 (en) * 2001-03-28 2002-10-10 University Of South Florida Materials and methods for treatment of cancer and identification of anti-cancer compounds
JP2003104812A (ja) * 2001-07-26 2003-04-09 Nippon Fine Chem Co Ltd トリテルペン配糖体を含有する害虫防除剤

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; CHENG, LANYING ET AL: "Effect of the total saponin extract from the shoots of Momordica charantia L. on anti-virus HSV-II activity", XP002369613, retrieved from STN Database accession no. 2005:439545 *
FUIOKA TOSHIHIRO ET AL: "Antitumor agents 171. Cytotoxicities of lobatosides B,C,D, and E, cyclic bisdesmosides isolated from Actinostemma lobatum maxim", BIOORGANIC AND MEDICINAL CHEMISTRY LETTERS, vol. 6, no. 23, 1996, pages 2807 - 2810, XP004136084, ISSN: 0960-894X *
MULHOLLAND DULCIE A ET AL: "Cucurbitane triterpenoids from the leaves of Momordica foetida", PHYTOCHEMISTRY (OXFORD), vol. 45, no. 2, 1997, pages 391 - 395, XP004293134, ISSN: 0031-9422 *
MURAKAMI TOSHIYUKI ET AL: "Medicinal foodstuffs. XXI. Structures of new cucurbitane-type triterpene glycosides, goyaglycosides-a, -b, -c, -d, -e, -f, -g, and h, and new oleanane-type triterpene saponins, goyasaponins I, II, and III, from the fresh fruit of Japanese Momordica charantia L", CHEMICAL AND PHARMACEUTICAL BULLETIN (TOKYO), vol. 49, no. 1, January 2001 (2001-01-01), pages 54 - 63, XP002367088, ISSN: 0009-2363 *
OKABE H ET AL: "STRUCTURES OF MOMORDICOSIDE F-1 MOMORDICOSIDE F-2 MOMORDICOSIDE G MOMORDICOSIDE I MOMORDICOSIDE K AND MOMORDICOSIDE L NOVEL CUCURBITACINS IN THE FRUITS OF MOMORDICA-CHARANTIA", TETRAHEDRON LETTERS, vol. 23, no. 1, 1982, pages 77 - 80, XP002367091, ISSN: 0040-4039 *
OKABE H ET AL: "Studies on the constituents of Momordica charantia L. IV. Characterization of the new cucurbitacin glycosides of the immature fruits. (2) Structures of the bitter glycosides, momordicosides K and L", CHEMICAL AND PHARMACEUTICAL BULLETIN 1982 JAPAN, vol. 30, no. 12, 1982, pages 4334 - 4340, XP002367092 *
PATENT ABSTRACTS OF JAPAN vol. 2003, no. 08 6 August 2003 (2003-08-06) *
SICHUAN DAXUE XUEBAO, ZIRAN KEXUEBAN , 41(3), 641-643 CODEN: SCTHAO; ISSN: 0490-6756, June 2004 (2004-06-01) *
YASUDA M ET AL: "STRUCTURES OF MOMORDICINES I II AND III THE BITTER PRINCIPLES IN THE LEAVES AND VINES OF MOMORDICA-CHARANTIA", CHEMICAL AND PHARMACEUTICAL BULLETIN (TOKYO), vol. 32, no. 5, 1984, pages 2044 - 2047, XP002367093, ISSN: 0009-2363 *

Also Published As

Publication number Publication date
WO2006018019A2 (de) 2006-02-23
DE102004040690A1 (de) 2006-03-02

Similar Documents

Publication Publication Date Title
WO2006015159A3 (en) Potassium channel inhibitors
WO2005030791A3 (en) Isoquinolinone potassium channel inhibitors
WO2009082701A8 (en) Hcv protease inhibitors and uses thereof
IL213342A0 (en) Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
IL236013A (en) Edamantyl acetamide derivatives as 11-beta-hydroxysteroid dehydrogenase enzyme inhibitors
WO2005030129A3 (en) Quinoline potassium channel inhibitors
NO20052887D0 (no) Pyridazinonderivater som GSK-3Beta inhibitorer.
WO2005046578A3 (en) Isoquinolinone potassium channel inhibitors
WO2007050348A3 (en) Potassium channel inhibitors
WO2007133290A3 (en) Anti-ox40l antibodies and methods using same
WO2002074748A8 (en) Metalloproteinase inhibitors
WO2005123672A3 (en) Kinase inhibitors
WO2003074500A3 (en) N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors
WO2007084290A3 (en) Compositions of an anticonvulsant and psychotherapeutic and methods of using the same for reversing weight gain
WO2005030130A3 (en) Isoquinoline potassium channel inhibitors
WO2009042114A3 (en) Phenazine derivatives and uses thereof
IL190730A0 (en) Potassium channel inhibitors
WO2007019526A3 (en) Compositions and methods for controlling glucose and lipid uptake from foods
WO2007042524A3 (en) Treating diabetes using inhibitors of il-1
ZA200705474B (en) Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
WO2007014250A3 (en) Abl kinase inhibition
ZA200609946B (en) Adamantyl-acetamide derivatives as inhibitor of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
WO2006014877A3 (en) Potassium channel inhibitors
WO2006127368A3 (en) Methods for synthesizing imidazotriazinones
WO2007077329A3 (fr) Nouvelle association d'un inhibiteur du courant if sinusoïdal et d'un inhibiteur calcique et les compositions pharmaceutiques qui la contiennent

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase